Meghmani Q1: consolidated PAT nearly quadruples YoY to ₹48 Cr on margin rebound, revenue slips 12%

Meghmani Organics reported a profitability-led first quarter: consolidated PAT rose to ₹48.19 Cr from ₹12.68 Cr a year ago (+280% YoY) even as consolidated revenue fell 11.5% YoY to ₹542.83 Cr. There were no exceptional items on either side, so the profit surge is underlying, not accounting-driven — net margin expanded to ~8.9% from ~2.0%. The engine was cost and mix, not volume: consolidated finance costs more than halved to ₹13.05 Cr (from ₹29.47 Cr), the Pigments segment swung to a ₹2.85 Cr result from a ₹11.15 Cr loss, and the Others (Crop Nutrition/merchant) segment turned to a ₹7.02 Cr profit from a loss — while Agrochemicals, the topline mainstay, saw revenue drop ~14.5% YoY to ₹391.61 Cr with segment profit roughly flat at ₹70.06 Cr.

Basis matters this quarter. Standalone PAT of ₹57.60 Cr (+42% YoY) tells a much milder story than the +280% consolidated print; the gap is that subsidiary losses narrowed dramatically (group carried ~₹9.4 Cr of subsidiary drag this quarter versus ~₹28 Cr a year ago), so the consolidated number flatters the operational improvement. Readers will see both — the ~238-point divergence in YoY PAT growth is entirely the subsidiary turnaround, chiefly Kilburn Chemicals/pigments. Sequentially the base was depressed (Q4 FY26 PAT ₹8.03 Cr), so the +500% QoQ jump overstates momentum.

The stock went into the print at ₹59.94, up 23.1% over the past month of trading.

For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 2 consecutive quarters.

Against management's own FY27 guidance the read is mixed: the targeted margin rebound and Pigments profitability recovery are clearly materialising, but the promised double-digit Crop Protection revenue growth did not show — core Agrochemicals revenue is down, not up. No formal street consensus was available for the quarter. The board separately appointed Naresh Prajapati as Company Secretary and Compliance Officer effective July 29, and the proposed amalgamation of wholly-owned subsidiaries Kilburn Chemicals and Meghmani Crop Nutrition (appointed date Jan 1, 2026) remains pending effectiveness with no accounting impact yet given. The July 22 volume-movement clarification sits against a quarter where the profit recovery ran ahead of the topline.